Back to News
Market Impact: 0.2
EVERY Strengthens Global IP Moat with 65th Granted Patent, Expanding Foundational Protection for Precision-Fermented Ovalbumin
Source: Business Wire
Patents & Intellectual PropertyHealthcare & Biotech
EVERY announced its 65th granted patent globally, expanding protection for recombinant ovalbumin across multiple production hosts. The announcement indicates continued intellectual-property development, but the article provides no financial figures or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Sovereign wealth funds' China and Hong Kong investments surge 190% after a bruising slump
- Arcus Biosciences prices $250 million stock offering at $17.50
- AstraZeneca says U.S. FDA approves rare kidney disease drug
- UnitedHealth's Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?
- Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- Why is Intuitive Surgical stock tumbling today?